The AMR Global Health Academy advances applied learning to strengthen antimicrobial stewardship, diagnostic reasoning, and health system implementation — particularly in low- and middle-income settings. Our focus is simple: move from evidence to decision to implementation.
Practical, Case-Based Learning for Diagnostic Reasoning and Stewardship
0
+
Learners
0
Countries Reached
Global
0
Faculty Network
0
Languages
Diagnostics & Laboratory Decision Making
Starting with the Decision Point, follow the pathway from Knowledge → Application → Advanced Decision-Making. Click the linked course titles and supporting lessons to continue your learning.
Blood Culture Positive: Contaminant or True Infection?
SUPPORTING LESSONS:
- Antimicrobial Susceptibility Testing (AST)
- Methods for Detecting the Pattern of Antibiotic Susceptibility or Resistance
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
When AST Changes the Plan
SUPPORTING LESSONS:
- Methods for Detecting the Pattern of Antibiotic Susceptibility or Resistance in Human Pathogens
- Rapid Methods for Pathogen Identification and Antimicrobial Resistance Testing (ART)
- Use of AMR Testing Results to Improve Clinical Care
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
Colonization or Infection?
SUPPORTING LESSONS:
- Examples of Healthcare-Associated Pathogens
- Screening HAIs in Healthcare Settings
- Sharing Laboratory Data
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
Stewardship in Clinical Practice
Starting with the Decision Point, follow the pathway from Knowledge → Application → Advanced Decision-Making. Click the linked course titles and supporting lessons to continue your learning.
Should I Prescribe an Antibiotic?
III. ADVANCED DECISION-MAKING
Building Capacity for AMR Surveillance in Low- and Middle-Income Countries
RECOMMENDED LESSON:
SUPPORTING LESSONS:
- The Lab-Clinician Interface
- Antimicrobial Stewardship and the Prevention and Control of HAIs
- Interactive Activity: Cost Savings with AMS Programs
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
Is IV Therapy Still Necessary?
I. KNOWLEDGE
AMR Life Support Course (AMLS)
RECOMMENDED MODULE:
FOCUS LESSON:
- Principles to Remember (De-escalation)
II. APPLICATION
AMR Life Support Course (AMLS)
RECOMMENDED MODULE:
FOCUS LESSON:
- Advanced Management Considerations (Surgical indications and oral step-down therapy)
SUPPORTING LESSONS:
- Use of AMR Testing Results to Improve Clinical Care: Urinary tract infections (UTI)
- The Laboratory in Detection of HAIs and Guiding Patient Management
- Why Bloodstream Infections Matter
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
How Long Is Long Enough?
I. KNOWLEDGE
AMR Life Support Course (AMLS)
RECOMMENDED MODULE:
FOCUS LESSONS:
- Empiric Treatment of CAP (Duration of therapy for pneumonia)
- Shorter Antimicrobial Duration in CAP: Evidence and Interpretation (Duration of therapy for pneumonia)
III. ADVANCED DECISION-MAKING
Building Capacity for AMR in Low- and Middle-Income Countries
RECOMMENDED LESSON:
- Building AMR Champions (Healthcare Providers’ Role in AMR)
SUPPORTING LESSONS:
- Use of AMR Testing Results to Improve Clinical Care: Gastrointestinal infections
- Major HAIs
- Surgical Site Infections (SSI): Targeted Therapy & Resistance
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
Healthcare-Associated Infections & Infection Prevention and Control (IPC)
Starting with the Decision Point, follow the pathway from Knowledge → Application → Advanced Decision-Making. Click the linked course titles and supporting lessons to continue your learning.
Outbreak or Coincidence?
I. KNOWLEDGE
Laboratory in Prevention and Control of Healthcare-Associated Infections (HAIs)
RECOMMENDED LESSON:
FOCUS:
- Understanding how laboratory findings, infection patterns, and surveillance data can signal a possible outbreak and support early IPC decisions.
II. APPLICATION
Laboratory in Prevention and Control of Healthcare-Associated Infections (HAIs)
RECOMMENDED LESSON:
FOCUS:
- Reviewing a cluster of cases, assessing epidemiological links, coordinating laboratory and IPC investigations, and initiating appropriate control measures without waiting for molecular confirmation.
III. ADVANCED DECISION-MAKING
AMR Problem Solving Cases (HAIs)
RECOMMENDED CASE:
FOCUS:
- Applying epidemiological and microbiological evidence to recognize a suspected outbreak of carbapenem-resistant Klebsiella pneumoniae, determine when to escalate, and coordinate a multidisciplinary investigation.
SUPPORTING LESSONS:
- Building Laboratory Surveillance for HAIs (Focus: Screening, monitoring, and laboratory surveillance to identify potential healthcare-associated transmission.)
- Major HAI Pathogens (Focus: Klebsiella pneumoniae and other important healthcare-associated pathogens.)
- Role of the Lab for HAIs (Focus: The laboratory’s contribution to HAI detection, monitoring, and control.)
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
Screen, Isolate, or Wait?
I. KNOWLEDGE
Laboratory in Prevention and Control of Healthcare-Associated Infections (HAIs)
RECOMMENDED LESSON:
FOCUS:
- Understanding the distinction between colonization and infection, and why patients carrying resistant organisms may pose a transmission risk even without symptoms.
II. APPLICATION
Microbiology Laboratory Testing to Address AMR
RECOMMENDED LESSON:
FOCUS:
- Applying laboratory screening and monitoring principles to assess patients with a history of resistant-organism colonization and inform timely IPC decisions.
III. ADVANCED DECISION-MAKING
Laboratory in Prevention and Control of Healthcare-Associated Infections (HAIs)
RECOMMENDED LESSON:
FOCUS:
- Applying CRE screening history, transmission risk, and available isolation resources to determine appropriate precautions and patient placement in consultation with the IPC team.
SUPPORTING LESSONS:
- Resistance Mechanisms (Focus: Understanding carbapenem resistance and its implications for infection prevention.)
- Antimicrobial Stewardship (AMS) (Focus: IPC fundamentals and the relationship between antimicrobial stewardship and HAI prevention.)
- Discussion Forum (Focus: Reflecting on national and institutional guidelines for IPC and HAI control.)
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
The ICU Acinetobacter Question
I. KNOWLEDGE
Laboratory in Prevention and Control of Healthcare-Associated Infections (HAIs)
RECOMMENDED LESSON:
FOCUS:
- Understanding Acinetobacter baumannii as a healthcare-associated pathogen, including its environmental persistence, resistance characteristics, and potential for transmission in ICUs.
II. APPLICATION
Laboratory in Prevention and Control of Healthcare-Associated Infections (HAIs)
RECOMMENDED LESSON:
FOCUS:
- Using microbiology findings and surveillance data to identify multidrug-resistant organisms, recognize potential transmission risks, and inform timely IPC action.
III. ADVANCED DECISION-MAKING
AMR Problem Solving Cases (HAIs)
RECOMMENDED CASE:
FOCUS:
- Applying clinical, microbiological, and IPC information to recognize potential ICU transmission, assess outbreak risks, and coordinate appropriate infection prevention and control responses.
SUPPORTING LESSONS:
- Role in the Prevention and Control of HAIs in Healthcare Settings (Focus: Understanding coordination between microbiology laboratories and IPC teams.)
- Role of the Lab for HAIs (Focus: Using laboratory findings to support infection prevention decisions and surveillance.)
To earn a course certificate, complete all required lessons and assessments within the course.
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.
The AMR Global Health Academy is a global, virtual learning community advancing antimicrobial stewardship and diagnostic excellence.
Through free, case-based courses and practical implementation tools, the Academy supports public health professionals, laboratory leaders, clinicians, and ministry partners—particularly in low- and middle-income countries. Learners gain structured, practice-driven CPD designed to strengthen real-world decision-making. Available in English, French, Spanish, and Portuguese.
What the AMR Global Health Academy Delivers
Practical AMR Education
Structured, case-based CPD focused on diagnostics, stewardship, and real-world implementation.
Global Peer Community
Connecting public health leaders, laboratories, clinicians, and institutions across 170 countries.
Strengthened Decision-Making Capacity
Equipping frontline professionals with tools to improve testing, prescribing, and infection prevention practices.
Systems-Level Impact
Supporting ministries, universities, and professional societies to strengthen AMR capacity at scale.
AMR Academy Hubs
From Learning to Implementation
AMR Academy Hubs extend learning into national and regional practice by connecting the Academy with ministries, professional societies, universities, laboratories, healthcare institutions, and other partners.
Local Context → Workforce Activation → Implementation
Hubs create the connection between what people learn through the Academy and what happens in practice.
Local Context →
Academy learning is contextualized with country and regional evidence, priorities, guidance, and expertise, while remaining part of the shared global Academy.
Workforce Activation →
Hubs connect learning with professional societies, universities, health facilities, ministries, and other partners to engage the workforce through structured learning pathways, CPD, peer learning, and professional development.
Implementation
Hubs support the application of knowledge in real-world settings—helping move education beyond course completion toward changes in practice, stronger systems, and measurable impact.
Explore the AMR Academy Hubs
AMR Academy Hubs reflect different models of partnership and implementation, shaped by local priorities, institutions, and workforce needs.
International Diagnostics Collaborative (IDC)
A global collaborative connecting diagnostics expertise, implementation experience, and partnerships to strengthen diagnostic systems and translate innovation into impact. An initiative of the Global Health Impact Group.
Coming Soon
Who the Academy Is Designed For
The AMR Global Health Academy serves:
- Public health professionals
- Laboratory leaders and diagnosticians
- Clinicians and antimicrobial stewardship teams
- Ministry of Health technical staff
- Universities and teaching institutions
- Professional societies and implementation partners
Built for professionals strengthening AMR response within health systems—particularly in low- and middle-income settings.
What the Academy Offers
- 1. Structured, Case-Based Courses
Practice-driven modules focused on diagnostics, stewardship, and implementation. - 2. Real-World LMIC Case Studies
Problem-solving scenarios grounded in frontline decision-making. - 3. Expert-Led Learning Series
Webinars and curated discussions on emerging technologies and policy shifts. - 4. Shared Country Lessons
Cross-country learning to accelerate implementation and avoid duplication. - 5. Global Professional Community
A growing network of AMR practitioners across 170 countries.
Academic & Scientific Leadership
The AMR Global Health Academy is guided by internationally recognized experts in antimicrobial resistance, diagnostics, public health, and implementation science.
Advisors represent leadership across Africa, Asia, Europe, and the Americas, strengthening global credibility and regional relevance.
- Dr Sayantan Banerjee
All India Institute of Medical Sciences Kalyani
Kalyanilisten - Dr Charles K. Cooper
bioMérieux | EVP & Chief Medical Officer - Dr Elizabeth Menezes
Brazilian Society of Clinical Analysis (SBAC) | President - Dr Amadou Sall
Institut Pasteur de Dakar | Director
- Prof Yap Boum II
Institut Pasteur de Bangui | Director - Dr Noah Fongwen
CLDS, Africa CDC | Diagnostics Access Coordinator - Dr Mark Miller
Clinical, Research, and Diagnostics Expert on AMR - Prof Yik-Ying (YY) Teo
Saw Swee Hock School of Public Health
National University of Singapore | Dean
- Dr Tom Chiller
Mycotic Diseases Branch, U.S. Centers for Disease Control and Prevention | Chief - Prof David Heymann
London School of Hygiene and Tropical Medicine - Dr Teri Roberts
Research, Public Health and Diagnostics Expert on AMR
NEWSLETTERS
Stay informed with the latest developments in the fight against antimicrobial resistance through our AMR Global Health Academy news briefs. Every month these briefs provide updates on new AMR testing, diagnostics, surveillance, educational resources, upcoming training opportunities, research breakthroughs, and policy advancements. We also present AMR problem-solving case studies and feature laboratories and AMR champions battling real-world AMR problems.
AMR Brief 9 - September 2026
AMR Brief 8 - August 2026
AMR Brief 7 - July 2026
AMR Brief 6 - June 2026
AMR Brief 5 - May 2026
AMR Brief 4 - April 2026
AMR Brief 3 - March 2026
AMR Brief 2 - February 2026
AMR Brief 1 - January 2026
AMR Newsletter 16 - December 2025
AMR Newsletter 15 - November 2025
AMR Newsletter 14 - October 2025
AMR Newsletter 13 - September 2025
AMR Newsletter 12 - August 2025
AMR Newsletter 11 - July 2025
AMR Newsletter 10 - June 2025
AMR Newsletter 9 - May 2025
AMR Newsletter 8 - April 2025
AMR Newsletter 7 - March 2025
AMR Newsletter 6 - February 2025
AMR Newsletter 5 - January 2025
AMR Newsletter 4 - December 2024
AMR Newsletter 3 - September/October 2024
AMR Newsletter 2 - July/August 2024
AMR Newsletter 1 - May/June 2024
REPORTS
AMR Survey for Surveillance Capacity
Antimicrobial Resistance 2024 Educational Series – Report January 2025
Support for this initiative has been provided through an unrestricted educational grant from bioMérieux.